Nanobiotix (NASDAQ: NBTX) resumes Euronext Paris trading after offering halt
Filing Impact
Filing Sentiment
Form Type
6-K
Rhea-AI Filing Summary
Nanobiotix S.A. reports that trading in its ordinary shares on the regulated market of Euronext Paris has resumed as of 3:30 p.m. Paris time / 9:30 a.m. New York time on May 21, 2026.
Trading had been halted earlier that day at the company’s request in connection with a previously announced global securities offering. This global offering includes a U.S. public offering of American Depositary Shares, each representing one ordinary share with a nominal value of €0.03, and an international offering of ordinary shares and pre-funded warrants to qualified investors in Europe and certain other countries outside the United States and Canada.
Positive
- None.
Negative
- None.
Key Figures
Trading resumption time: 3:30 p.m. Paris / 9:30 a.m. New York
Trading halt time: 9:00 a.m. CEST
Ordinary share nominal value: €0.03 per share
3 metrics
Trading resumption time
3:30 p.m. Paris / 9:30 a.m. New York
Time trading resumed on Euronext Paris on May 21, 2026
Trading halt time
9:00 a.m. CEST
Time trading was halted on May 21, 2026 at company’s request
Ordinary share nominal value
€0.03 per share
Nominal value of each Nanobiotix ordinary share represented by an ADS
Key Terms
American Depositary Shares, pre-funded warrants, Global Offering, qualified investors, +1 more
5 terms
pre-funded warrants financial
"an offering of (a) its Ordinary Shares and (b) pre-funded warrants to subscribe for Ordinary Shares"
Pre-funded warrants are financial instruments that give investors the right to purchase a company's stock at a set price, but with most or all of the purchase price paid upfront. They function like a coupon or gift card for stock, allowing investors to buy shares later at a fixed price, which can be beneficial if they want to avoid future price increases. This makes them important for investors seeking flexibility and certainty in their investment plans.
Global Offering financial
"the “International Offering” and, together with the U.S. Offering, the “Global Offering”"
A global offering is when a company sells its shares or other securities to investors in multiple countries at the same time, combining new shares and sometimes existing ones. It matters to investors because it can change how many shares are available, affect the stock’s price and liquidity, and bring in capital or let insiders cash out—much like a concert releasing tickets worldwide at once, expanding the buyer pool and influencing demand and resale value.
qualified investors financial
"exclusively addressed to “qualified investors” in Europe (including France) within the meaning of Article 2(e)"
Qualified investors are individuals or institutions that meet regulatory standards—such as a minimum income, net worth, or professional expertise—allowing them access to investment opportunities not open to the general public. Think of them as a financial "VIP" group: they can buy private deals, complex products, or early-stage securities that may offer higher returns but also carry greater risk and less public information, so their status matters because it changes what investments are available and what protections apply.
Regulation (EU) 2017/1129 regulatory
"within the meaning of Article 2(e) of Regulation (EU) 2017/1129, as amended"
An EU law that sets uniform rules for the detailed disclosure document companies must give when offering securities to the public or listing them on markets. It matters to investors because it forces issuers to present a clear, standardized “label” of information—risks, business model, finances and terms—so you can compare offerings and spot missing or misleading claims. Think of it as a required ingredient list and instructions for financial products sold across the EU.
FAQ
What did Nanobiotix (NBTX) announce in its latest Form 6-K?
Nanobiotix announced that trading in its ordinary shares on Euronext Paris resumed on May 21, 2026. Trading had been halted earlier that day at the company’s request in connection with a previously announced global securities offering.
What securities are included in Nanobiotix’s previously announced Global Offering?
The Global Offering consists of a U.S. public offering of American Depositary Shares and an international offering of ordinary shares and pre-funded warrants. The international tranche targets qualified investors in Europe and certain other countries, excluding the United States and Canada.